Serial 88319645
Live / Registered — Registered (as of 06 Dec 2022)
What this means for you
Registered since 06 Dec 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88319645
- Registration number
- 6918564
- Mark type
- Design / logo
- Filed
- 28 Feb 2019
- Published for opposition
- 30 Jul 2019
- Registered
- 06 Dec 2022
- Attorney of record
- Cynthia Johnson Walden
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of neurological diseases and neurodegenerative diseases
Owner
- Amylyx Pharmaceuticals, Inc., Cambridge, MA, US
- Amylyx Pharmaceuticals, Inc., Cambridge, MA, US
- Amylyx Pharmaceuticals, Inc., Cambridge, MA, US
Prosecution history
- 23 Feb 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 23 Feb 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 23 Feb 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 23 Feb 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 23 Feb 2026 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 06 Dec 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 06 Dec 2022 — REGISTERED-PRINCIPAL REGISTER
- 29 Oct 2022 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 28 Oct 2022 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 28 Sept 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 26 Sept 2022 — USE AMENDMENT FILED
- 26 Sept 2022 — TEAS STATEMENT OF USE RECEIVED
- 18 Mar 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Mar 2022 — SOU EXTENSION 5 GRANTED
- 07 Mar 2022 — SOU EXTENSION 5 FILED